Dawn Parsell Otto, Senior VP, Clinical Development at Tricida, Inc. (TCDA), sold 5,746 shares at $39.61 ($228K) on 2019-11-26, disclosed to the SEC on 2019-11-27.
Open-market sale of $228k TCDA by Senior VP, Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.59 | 739 | $29K | 12.9% |
| 2 | $39.60 | 1,616 | $64K | 28.1% |
| 3 | $39.60 | 1,884 | $75K | 32.8% |
| 4 | $39.61 | 1,507 | $60K | 26.2% |
| Total | $39.60 avg | 5,746 | $228K | 100% |
| Filing → |
| TCDA | SELL | 2020-04-30 | $172K | — | Filing → |
| TCDA | SELL | 2020-03-04 | $214K | — | Filing → |
| TCDA | SELL | 2020-02-05 | $242K | — | Filing → |